0000820081-14-000030.txt : 20140904
0000820081-14-000030.hdr.sgml : 20140904
20140904160729
ACCESSION NUMBER: 0000820081-14-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140902
FILED AS OF DATE: 20140904
DATE AS OF CHANGE: 20140904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLOSK STEVEN M
CENTRAL INDEX KEY: 0001192621
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 141083311
MAIL ADDRESS:
STREET 1: C/O CAMBREX CORP
STREET 2: ONE MEADOWLANDS PLZ
CITY: EAST RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-09-02
0000820081
CAMBREX CORP
CBM
0001192621
KLOSK STEVEN M
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
0
1
0
0
President & CEO
Common Stock
2014-09-02
4
M
0
60000
5.605
A
205870
D
Common Stock
2014-09-02
4
S
0
60000
22.0125
D
145870
D
Common Stock
2014-09-03
4
M
0
66257
5.605
A
212127
D
Common Stock
2014-09-03
4
S
0
66257
22.0156
D
145870
D
Stock Option (Right to Buy)
5.605
2014-09-02
4
M
0
60000
0
D
2015-05-14
Common Stock
60000
66257
D
Stock Option (Right to Buy)
5.605
2014-09-03
4
M
0
66257
0
D
2015-05-14
Common Stock
66257
0
D
The option, representing a right to purchase a total of 150,000 shares, became exercisable in four equal annual installments beginning on May 14, 2009, which was the first anniversary of the date on which the option was granted.
The price reported in Column 4 in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0 to $22.19 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0 to $22.135 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (3) to this Form 4.
Linda Kresse for Steven M. Klosk by POA
2014-09-04